Matches in SemOpenAlex for { <https://semopenalex.org/work/W3143142723> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W3143142723 abstract "The purpose of this study was to determine the disease-free and overall survival (DFS and OS, respectively) in 991 postgastrectomy gastric cancer patients untreated (n = 372) or treated with either oxaliplatin-based (n = 376) or docetaxel-based (n = 243) chemotherapy and to identify prognostic factors that could help establish subgroups of patients who would benefit from such treatment. The median follow-up duration was 55.3 months (range 31.2-90.8 months). Subgroup analyses revealed that gastric adenocarcinoma (DFS 56.9 vs 53.2 months, P = 0.180, v 2 = 1.802; OS not reached vs 70.7 months, P = 0.521, v 2 = 0.412), but not absolute signet ring cell (SRC) carcinoma (DFS 15.1/18.0 vs 10.1 months, P = 0.171/0.259, v 2 = 1.874/1.275; OS 21.0/ 26.1 vs 20.5 months, P = 0.551/0.196, v 2 = 0.355/1.674), patients undergoing either docetaxel- or oxaliplatin-based che- motherapy had a lower risk of recurrence and increased survival in comparison to those without chemotherapy. In the mixed SRC carcinoma patients, DFS and OS of patients treated with docetaxel-based regimen had a longer survival (DFS 50.1 vs 29.9 months, P = 0.046, v 2 = 3.987; OS not reached vs 48.6 months, P = 0.016, v 2 = 5.854) and lower risk of recurrence and death (DFS HR 0.540, 95 % CI 0.355-0.874, P = 0.012; OS HR 0.452, 95 % CI 0.259-0.790, P = 0.005) than oxaliplatin-based chemotherapy. Cumulatively, our results indicate that adjuvant chemotherapy is beneficial and that docetaxel-based regimen should be considered for patients with mixed SRC carcinoma." @default.
- W3143142723 created "2021-04-13" @default.
- W3143142723 creator A5022979609 @default.
- W3143142723 creator A5029861413 @default.
- W3143142723 creator A5044157129 @default.
- W3143142723 creator A5069764403 @default.
- W3143142723 date "2014-01-01" @default.
- W3143142723 modified "2023-09-26" @default.
- W3143142723 title "Evaluation of docetaxel- and oxaliplatin-based adjuvant chemotherapy in postgastrectomy gastric cancer patients reveals obvious survival benefits in docetaxel-treated mixed signet ring cell carcinoma patients" @default.
- W3143142723 cites W12636511 @default.
- W3143142723 cites W1509970002 @default.
- W3143142723 cites W1911358787 @default.
- W3143142723 cites W1920099977 @default.
- W3143142723 cites W1984202183 @default.
- W3143142723 cites W2029389980 @default.
- W3143142723 cites W2071808074 @default.
- W3143142723 cites W2106787323 @default.
- W3143142723 cites W2113947048 @default.
- W3143142723 cites W2118321353 @default.
- W3143142723 cites W2131597845 @default.
- W3143142723 cites W2131692910 @default.
- W3143142723 cites W2137991416 @default.
- W3143142723 cites W2165628099 @default.
- W3143142723 cites W2270225764 @default.
- W3143142723 cites W2414958338 @default.
- W3143142723 cites W79657813 @default.
- W3143142723 hasPublicationYear "2014" @default.
- W3143142723 type Work @default.
- W3143142723 sameAs 3143142723 @default.
- W3143142723 citedByCount "0" @default.
- W3143142723 crossrefType "journal-article" @default.
- W3143142723 hasAuthorship W3143142723A5022979609 @default.
- W3143142723 hasAuthorship W3143142723A5029861413 @default.
- W3143142723 hasAuthorship W3143142723A5044157129 @default.
- W3143142723 hasAuthorship W3143142723A5069764403 @default.
- W3143142723 hasConcept C121608353 @default.
- W3143142723 hasConcept C126322002 @default.
- W3143142723 hasConcept C141071460 @default.
- W3143142723 hasConcept C143998085 @default.
- W3143142723 hasConcept C189528381 @default.
- W3143142723 hasConcept C2776694085 @default.
- W3143142723 hasConcept C2780238495 @default.
- W3143142723 hasConcept C2780470880 @default.
- W3143142723 hasConcept C2780962732 @default.
- W3143142723 hasConcept C2781182431 @default.
- W3143142723 hasConcept C2781190966 @default.
- W3143142723 hasConcept C2781413609 @default.
- W3143142723 hasConcept C526805850 @default.
- W3143142723 hasConcept C71924100 @default.
- W3143142723 hasConcept C90924648 @default.
- W3143142723 hasConceptScore W3143142723C121608353 @default.
- W3143142723 hasConceptScore W3143142723C126322002 @default.
- W3143142723 hasConceptScore W3143142723C141071460 @default.
- W3143142723 hasConceptScore W3143142723C143998085 @default.
- W3143142723 hasConceptScore W3143142723C189528381 @default.
- W3143142723 hasConceptScore W3143142723C2776694085 @default.
- W3143142723 hasConceptScore W3143142723C2780238495 @default.
- W3143142723 hasConceptScore W3143142723C2780470880 @default.
- W3143142723 hasConceptScore W3143142723C2780962732 @default.
- W3143142723 hasConceptScore W3143142723C2781182431 @default.
- W3143142723 hasConceptScore W3143142723C2781190966 @default.
- W3143142723 hasConceptScore W3143142723C2781413609 @default.
- W3143142723 hasConceptScore W3143142723C526805850 @default.
- W3143142723 hasConceptScore W3143142723C71924100 @default.
- W3143142723 hasConceptScore W3143142723C90924648 @default.
- W3143142723 hasLocation W31431427231 @default.
- W3143142723 hasOpenAccess W3143142723 @default.
- W3143142723 hasPrimaryLocation W31431427231 @default.
- W3143142723 isParatext "false" @default.
- W3143142723 isRetracted "false" @default.
- W3143142723 magId "3143142723" @default.
- W3143142723 workType "article" @default.